Fri, March 23 – 10 Stories of The Day!

1 – Guideline: Venous thromboembolism in over 16s: reducing the risk of hospital-acquired deep vein thrombosis or pulmonary embolism – National Institute for Health and Care Excellence (NICE) (free)

2 – New Tool: Sustainable Development Goal (SDG) Tracker – Our World in Data (free)

Commentary: The U.N. Set 17 Goals To Make The World A Better Place. How’s It Doing? – NPR (free)

“The United Nations Sustainable Development Goals (SDGs) are targets for global development adopted in September 2015, set to be achieved by 2030. Here we present data across all available indicators from the Our World in Data database tracking progress towards these goals around the world”.

3 – When antibiotics turn toxic – Nature News (free)

“Commonly prescribed drugs called fluoroquinolones cause rare, disabling side effects. Researchers are struggling to work out why”.

4 – Associations of Monounsaturated Fatty Acids From Plant and Animal Sources With Total and Cardiovascular Mortality Risk – Circulation (link to abstract – presented at the American Heart Association’s Epidemiology and Prevention | Lifestyle and Cardiometabolic Health Scientific Sessions 2018)

Commentaries: Mono-unsaturated fats from plants, not animals may reduce risk of death from heart disease and other causes – AHA / ASA Newsroom (free) AND These plant-based fats could help you live longer – Medical News Today (free)

5 – Report: Violence and Mental Health: Opportunities for Prevention and Early Detection – National Academies Press (free PDF)

6 – A Randomized Trial of High-Flow Oxygen Therapy in Infants with Bronchiolitis – New England Journal of Medicine (free)

Commentaries: Efficacy of High-Flow O₂ Tx Test Outside ICU for Infants With Bronchiolitis? – MPR (free) AND High-flow O2 therapy feasible for infants with bronchiolitis – MedicalXpress (free) AND High-Flow Oxygen Improves Infant Bronchiolitis Outcomes – MedPage Today (free)

7 – FDA In Brief: FDA updates public information about known risk of lymphoma from breast implants (free) AND Breast Implant-Associated Anaplastic Large Cell Lymphoma – FDA Update (free)

Commentaries: More Cases Are Reported of Unusual Cancer Linked to Breast Implants – The New York Times (10 articles per month are free) AND Implant-Related Lymphoma Cases Rise – More than 400 cases reported to FDA – MedPage Today (free)

“Some 400 to 500 women worldwide have an unusual type of lymphoma linked to breast implants with textured surfaces. Experts say women considering implants should be told”. (via @NYTHealth see Tweet)

8 – Viewpoint: The Proposal to Lower P Value Thresholds to .005 – JAMA (free) (via @VinayPrasad82 see Tweet)

Related: What a nerdy debate about p-values shows about science — and how to fix it – VOX (free) AND Big names in statistics want to shake up much-maligned P value – Nature News (free) AND ‘One-size-fits-all’ threshold for P values under fire – Nature News (free) AND Statisticians issue warning over misuse of P values – Nature News (free) AND Understanding common misconceptions about p-values – The 20% Statistician (free) AND Statistical tests, P values, confidence intervals, and power: a guide to misinterpretations – European Journal of Epidemiology(free)

9 – Effect of tai chi versus aerobic exercise for fibromyalgia: comparative effectiveness randomized controlled trial – The BMJ (free)

Commentaries: Time to rethink exercise for fibromyalgia care – The BMJ Opinion (free) AND The unintended consequences of tai chi for fibromyalgia – The BMJ Opinion (free) AND Tai chi may be as effective for fibromyalgia as standard exercise – NHS Choices (free) AND Tai chi at least as beneficial as aerobic exercise for fibromyalgia – OnMedica (free)

10 – Efficacy of a single-dose regimen of inactivated whole-cell oral cholera vaccine: results from 2 years of follow-up of a randomised trial – The Lancet Infectious Diseases (free)

Invited commentary: Cholera control: one dose at a time (free)

“Our results indicate that when such emergencies occur in populations with endemic cholera, the challenges of successfully completing a two-dose regimen should not deter deployment of OCV, because older children and adults will be protected for at least 2 years by a single dose”. (via @Onisillos see Tweet)